News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
TempraMed Featured on Dr. Phil Show in National US Broadcast Highlighting the Risk of Temperature Exposure for Insulin and Other Medications
May 22, 2026
·
4 min read
Press Releases
Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering
May 21, 2026
·
5 min read
Press Releases
Britannia Life Sciences Provides Corporate Update
May 21, 2026
·
4 min read
Press Releases
TMC Group Commissions New Capacity to Support Next-Generation Radiotheranostics
May 21, 2026
·
3 min read
Press Releases
Restart Life Sciences Closes Dedicated Purchase Order Financing Private Placement; CEO Subscribes for 50% of Offering
May 21, 2026
·
4 min read
Press Releases
Theralase(R) Closes C$4.8 Million Offering
May 20, 2026
·
8 min read
Press Releases
Marvel Biosciences Announces Grant of Deferred Share Units
May 20, 2026
·
3 min read
Press Releases
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
May 20, 2026
·
8 min read
Press Releases
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology
May 20, 2026
·
8 min read
Press Releases
Resverlogix Closes US$2 Million Shares-for-Interest Private Placement
May 20, 2026
·
3 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us